• Affiliate Associate Professor, Global Health
  • Executive Vice-President, Product Development, Infectious Disease Research Institute

Infectious Disease Research Institute
1616 Eastlake Avenue East, Suite 400
Seattle, WA 98102
United States

Phone Number: 
Select from the following:

Anna Marie Beckmann is the Executive Vice President of Product Development and Regulatory Affairs at IDRI. She is responsible for guiding products through the transitional phase from pre-clinical research to evaluation in clinical trials. In the regulatory affairs arena, her group provides the necessary documentation to the U.S. Food and Drug Administration for review and approval of IDRI's vaccine and adjuvant candidates in human clinical trials. She is also responsible for IDRI's in-house pilot manufacturing facility that produces cGMP adjuvant formulations for Phase 1 vaccine clinical trials.

Anna Marie was a Senior Fellow in the STD Training Program at the University of Washington and a faculty member at the Fred Hutchinson Cancer Research Center, where her research focused on the pathogenesis of human papillomavirus infections (HPV) and the relationship between HPV infections and human anogenital cancers. In 1998 she joined Corixa Corporation as Director of Regulatory Affairs and worked on early stage clinical development of vaccines for infectious diseases and cancer.

Anna Marie Beckmann earned her PhD from the Department of Immunology and Infectious Diseases at Johns Hopkins University School of Public Health. Her thesis was focused on the pathobiology of infection with the human papillomaviruses JC and BK.

  • PhD (Johns Hopkins University)
  • BA (Evergreen State College)
Country Affiliations 
Health Topics 
  • Drug and Vaccine Development
  • Infectious Diseases (other than STDs)
  • Leishmaniasis
  • Neglected Diseases, Tropical Medicine (incl. Parasites)
DGH Centers, Programs and Initiatives and Affiliated Organizations 

Vaccines for neglected diseases


Roberts, M.C., D.B. No, J.M. Marzluff, J.H. DeLap, and R. Turner. Vancomycin resistant Enterococcus spp. from crows and their environment in Metropolitan Washington State, USA: Is there a correlation between VRE positive crows and the environment? Vet Microbiol. 194:48-54, 2016. http://www.sciencedirect.com/science/article/pii/S0378113516300220

Michael, K.E., D. No, and M.C. Roberts. Methicillin-resistant Staphylococcus aureus (MRSA) isolates from surfaces and personnel at a hospital laundry facility. J. Appl Microbiol. 121:846-854, 2016. http://onlinelibrary.wiley.com/doi/10.1111/jam.13202/pdf

Soge, OO, D. No, K. Michael, J. Dankoff, J. Lane, K. Vogel, J. Smedley, and M.C. Roberts. Transmission of MDR MRSA between primates personnel and environment at a United States primate center. J. Antimicrob. Chemother. 71:2798-2803, 2016. doi:10.1093/jac/dkw236

Michael, K., D. No, J. Dankoff, K. Lee, E. Lara-Crawford, and M.C. Roberts. Clostridium difficile environmental contamination within a clinical laundry facility in the USA. FEMS Microbiol. Lett. http://femsle.oxfordjournals.org/content/femsle/early/2016/10/14/femsle.fnw236.full.pdf Press release from journal

Michael, K.E., D. No, and M.C. Roberts. vanA positive multidrug-resistant Enterococcus spp. isolated from surfaces of a US hospital facility. J Hosp. Infect. 95:218-223, 2017. http://www.sciencedirect.com/science/article/pii/S0195670116304637